Q3 2024 Bonesupport Holding AB Earnings Call Transcript
Key Points
- Bonesupport Holding AB (BOEUF) reported a significant sales growth of over 50% year-on-year, reaching SEK238 million in Q3 2024.
- The company achieved a record operating result of SEK48 million before incentive provisions, with a reported EBIT of SEK41 million.
- Cerament G in the US experienced a remarkable 114% year-over-year growth, now accounting for 50% of total sales in the quarter.
- The Solario study, which has been ongoing for over four years, showed positive outcomes, potentially leading to modified treatment protocols and reduced systemic antibiotic use.
- Bonesupport Holding AB (BOEUF) is making good progress in preparing for market entry into the spinal fusion segment, with several preclinical studies underway.
- There was a higher-than-expected negative seasonality impact in Europe, exacerbated by healthcare staffing disruptions, leading to fewer surgeries and challenging market access.
- Sales and marketing expenses increased significantly, amounting to SEK102 million compared to SEK67.6 million the previous year.
- The gross margin dropped slightly due to a weaker US dollar, although it remained strong at 94.7%.
- The company faces challenges in training surgeons and nurses, with only 1,000 out of 20,000 US orthopedic surgeons trained on Cerament G so far.
- Despite strong sales growth, there is potential for disruptions in hospital systems that could temporarily halt the use of Cerament G.
Hello, Welcome everyone to Bonesupport quarter three 2024 results call. My name is Emil Billbäck and I'm making this broadcast as always together with Håkan Johansson, our CFO by my side.
So, we will use the next twenty-five minutes to guide you through the presentation of the third quarter results. And then we will open up the line for question and answers.
But before going through the presentation, we would like to draw your attention to the disclaimers covering any forward-looking statements that we will be making today.
So let's start the presentation and go to slide three. I would like to start the entire presentation with some condensed highlights from the report that we released this morning. So overall quarter-three results sales were at SEK238 million which corresponds to a reported growth of over 50% year on year. In constant exchange rate the growth was 54%.
The strong sales resulted in a record operating results before incentive provisions, the operating results was SEK48 million. The
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
